NIH-funded research NIH-funded research

Finding new treatments for inflammation that causes early birth

Official title: Discovery of Novel Therapeutics for Inflammation Induced Preterm Birth

Funded at Vanderbilt University Medical Center · NIH-11119417 · Data updated 2026-11-12

This study is looking at how inflammation and infections can cause babies to be born too early, and it's for anyone interested in finding new ways to prevent early labor by developing better treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2024
Project endJuly 31, 2027
Funding year2024
Award (this year)$248,999
NIH project number4R00HD108420-03
Project IDNIH-11119417 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals at risk of preterm birth due to inflammation or infection.

Less likely to help

Patients who are not pregnant or those whose preterm birth is not related to inflammation or infection may not benefit from this research.

What this research studies

This research focuses on understanding how inflammation and infection can lead to preterm birth, which occurs before 37 weeks of pregnancy. The project involves developing new therapeutic approaches to manage these conditions using advanced techniques in gestational tissue modeling. The research will be conducted at Vanderbilt University Medical Center, where the team will utilize a combination of hands-on training, coursework, and mentorship to explore innovative drug discovery methods. The ultimate goal is to create effective interventions that can help prevent early labor caused by infections.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly reduce the incidence of preterm birth and improve outcomes for infants.

How similar studies have gone: Previous research has shown promise in developing therapies for preterm birth, but this approach is innovative and aims to address specific inflammatory triggers.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Siricilla, Shajila — Vanderbilt University Medical Center
  • Study coordinator: Siricilla, Shajila

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.